Letters

Angiotensin receptor blockers and myocardial infarction

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7502.1270-a (Published 26 May 2005) Cite this as: BMJ 2005;330:1270

Cautions voiced are biologically credible

  1. Zaheer R Yousef, specialist registrar (zypusef@dircon.co.uk),
  2. Francisco Leyva, consultant cardiologist,
  3. Christopher Gibbs, consultant cardiologist
  1. Department of Cardiology, Good Hope Hospital, Sutton Coldfield, West Midlands B75 7RR

    Editor—We agree with Verma and Strauss that it is naive to consider that angiotensin receptor blockers are like angiotensin converting enzyme (ACE) inhibitors, but without the cough.1 Although the evidence is conflicting, the hypothesis that angiotensin receptor blockers may predispose to myocardial infarction when used in preference to ACE inhibitors warrants further attention.

    Long term clinical benefits of …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe